|
Keynote Forum |
|
|
Day 1: Morning, July. 15, 2021 |
|
|
Moderator |
Dr. Mattias von Herrath, Vice President/Head NovoNordisk; Professor/Director of the Diabetes Center, La Jolla Institute, USA |
|
Time |
Speeches and Speakers |
|
09:00-09:05 |
Chair's Introduction |
|
09:05-09:30 |
Title: Tankyraseinhibitors: Evidence for Therapeutic Potential in Immuno-oncology Dr. Luc Van Hijfte, SVP Medicinal Chemistry, Symeres, the Netherlands |
|
09:30-09:55 |
Title: TBD Dr. Mattias von Herrath, Vice President/Head NovoNordisk; Professor/Director of the Diabetes Center, La Jolla Institute, USA |
|
09:55-10:20 |
Title: Nanoparticles for Gene and Drug Delivery: Applying Light Scattering to Screening and Characterization Dr. Daniel Some, Principal Scientist, Wyatt Technology Corporation, USA |
|
10:20-10:45 |
Title: The Role of ABC Membrane Transporters in Personalized Diagnostics and Drug Treatment Dr. Balazs Sarkadi, Professor, Semmelweis University, Hungary |
|
10:45-11:10 |
Title: Partnering with Pfizer – Introduction to Emerging Science & Innovation Dr. Uwe Schoenbeck, Senior Vice President & Chief Scientific Officer, Worldwide R & D, Pfizer, USA |
|
11:10-11:35 |
Title: New Innovative Ways to Enhance Treatment Targeting and Individualization: The Complementary Use of Predicting Modeling and Machine Learning in the Field of Diabetes and Metabolic Disorders Dr. Zsolt Bosnyak, VP, Global Medical Head Diabetes, Sanofi, France |
|
Session 1-1: Enhancing Bioavailability with New Technologies and Strategies |
|
|
Day 1: Afternoon, July. 15, 2021 |
|
|
Chair |
Dr. Finn Bauer, Head of Solid Formulation R&D, Merck KGaA, Germany |
|
Time |
Speeches and Speakers |
|
13:30-13:35 |
Chair's Introduction |
|
13:35-14:00 |
Keynote Speech Title: Enhancing Bioavailability through Impregnation of Active Pharmaceutical Ingredients into Porous Carriers Dr. Benjamin J. Glasser, Professor, Director, Pharmaceutical Engineering Program, Department of Chemical and Biochemical EngineeringRutgers, The State University of New Jersey, USA |
|
14:00-14:25 |
Title: TBD Dr. Gamal M. Mahrous, Professor, College of Pharmacy, King Saudi University, Saudi Arabia |
|
14:25-14:50 |
Title: Stabilization of Poor Glass-forming APIs with Mesoporous Silica Dr. Finn Bauer, Head of Solid Formulation R&D, Merck KGaA, Germany |
|
14:50-15:15 |
Title: Using AI Modelling to Characterise Pharmaceutical Excipients Dr. Michael Gamlen, Chief Scientific Officer, Gamlen Tableting Ltd, UK |
|
15:15-15:30 |
Coffee Break |
| 15:30-15:55 |
Speech Opportunity Available |
| 15:55-16:20 |
Speech Opportunity Available |
| 16:20-16:45 |
Speech Opportunity Available |
|
Session 2-1: Advances in Drug Delivery Technologies |
|
|
Day 1: Afternoon, July. 15, 2021 |
|
|
Chair
|
Dr. Faz Chowdhury, CEO, Nemaura Pharma Limited, UK
|
|
Time |
|
|
13:30-13:35 |
Chair's Introduction |
|
13:35-14:00 |
Title: Exploiting Expanding-CO2 Properties to Obtain Structured Lipid Microparticles as Delivery Systems Dr. Pierandrea Esposito, Associate Director, SITEC pharmabio, Spain |
|
14:00-14:25 |
Title: Microneedle Based Transdermal Drug Delivery for Vaccines, Proteins and Peptides Dr. Faz Chowdhury, CEO, NemauraPharma Limited, UK |
|
14:25-14:50 |
Title: MicroJet Reactor Technology, A Novel Approach to Overcome Bioavailability Challenges Dr. Pascale Clement, Chief Technology Officer, Leon-nanodrugs GmbH, Germany |
|
14:50-15:15 |
Title: Lipid Based Excipients – 4.0 Dr. Dieter Scherer, Managing Director, ApisPharma AG, Switzerland |
|
15:15-15:30 |
Coffee Break |
| 15:30-15:55 |
Speech Opportunity Available |
| 15:55-16:20 | Title: TBD Dr. Alexander Vilesov, I. P. Pavlov St. Petersburg 1st State Medical University, Russa |
| 16:20-16:45 | Title: Use of Pseudoboehmite as Drug Delivery System for Simvastatin Dr. Antonio Hortencio Munhoz, Professor, Universidade Presbiteriana Mackenzie, Brazil |
| 16:45-17:10 |
Speech Opportunity Available |
|
Session 3-1: New Oral, Transmucoadhesive, and Buccal Drug Delivery |
|
|
Day 1: Afternoon, July. 15, 2021 |
|
|
Chair |
Call for Chair |
|
Time |
Speeches and Speakers |
|
13:30-13:35 |
Chair's Introduction |
|
13:35-14:00 |
Title: Modern Oral Drug Delivery Systems for Our Society – Concepts and Technologies Dr. Norbert Poellinger, Head of Technology Development, Pharmaceutical Services, Glatt Pharmaceutical Services GmbH & Co. KG, Germany |
|
14:00-14:25 |
Speech Opportunity Available |
|
14:25-14:50 |
Title: A Microneedle Platform for Buccal Macromolecule Delivery Dr. Ester Caffarel-Salvador, Associate Director, LEO Pharma / Research Affiliate at Massachusetts Institute of Technology, USA |
|
14:50-15:15 |
Title: Safety of Oral Administration of PMF a Fraction Derived From Camel Urine: Acute Study on Mice Dr. Faten Khorshid, Professor, King Abdulaziz University (KAU), Saudi Arabia |
|
15:15-15:30 |
Coffee Break |
|
Session 5-1: Molecule Drugs Formulation |
|
|
Day 1: Afternoon, July. 15, 2021 |
|
|
Chair |
Call for Chair |
|
Time |
|
|
13:30-13:35 |
Chair's Introduction |
|
13:35-14:00 |
Title: Delivery of Long Acting Formulations Dr. Barbara Lead, Chief Executive Officer, Oval Medical Technologies Limited, UK |
|
14:00-14:25 |
Title: Personalised Tablets – Opportunities and Challenges Dr. Michael Gamlen, Chief Scientific Officer, Gamlen Tableting Ltd, UK |
|
14:25-14:50 |
Speech Opportunity Available |
|
14:50-15:15 |
Speech Opportunity Available |
|
15:15-15:30 |
Coffee Break |
|
© 2003-2021 All rights reserved by BIT Congress |